From: Rapid Analgesia for Prehospital hip Disruption (RAPID): findings from a randomised feasibility study
 | Experimental | Usual care | Difference (95% CI) |
---|---|---|---|
Primary outcomes | |||
 Mortality/N | 31 | 26 |  |
  Died within 6 months, n (%) | 4 (13%) | 6 (23%) | -10% (−31% to + 10%) |
 SF-12 @ 1 month/N | 14 | 9 |  |
  Physical Health mean (SD) | 30.1 (7.1) | 36.3 (10.2) | − 6.2 (− 13.6 to + 1.4) |
  Mental Health mean (SD) | 40.6 (12.9) | 34.4 (15.1) | 6.2 (− 6.1 to + 18.4) |
 SF-12 @ 6 months/N | 4 | 2 |  |
  Physical Health mean (SD) | 34.2 (10.0) | 42.6 (14.9) | − 8.5 (− 36.0 to + 19.0) |
  Mental Health mean (SD) | 44.3 (18.4) | 57.8 (4.6) | − 13.5 (− 52.2 to + 25.2) |
Secondary Outcomes | |||
 Satisfaction with care/N | 20 | 13 |  |
  Mean (SD) | 3.4 (0.4) | 3.5 (0.5) | − 0.1 (− 0.4 to + 0.2) |
 Modified Rivermead Mobility Index | |||
  One month, N | 18 | 12 |  |
   Mean (SD) | 5.2 (3.2) | 6.7 (3.3) | − 1.4 (− 3.9 to + 1.0) |
  Six months, N | 7 | 4 |  |
   Mean (SD) | 8.3 (3.2) | 9.8 (2.5) | − 1.5 (− 5.8 to + 2.8) |
 Pain score, N | 23 | 14 |  |
  Mean (SD) | 3.7 (2.7) | 4.1 (2.7) | − 0.4 (− 2.3 to + 1.5) |
 Medication by paramed/N | 31 | 26 |  |
  Entonox % (n) | 3% (1) | 4% (1) | − 0.6% (− 10% to + 9%) |
  Paracetamol % (n) | 52% (16) | 81% (21) | − 29% (− 52% to + 5%) |
  Morphine % (n) | 42% (13) | 81% (21) | − 39% (− 62% to − 16%) |
  Ondansetron % (n) | 35% (11) | 23% (6) | + 12% (− 11% to + 36%) |
 Time with participant/N | 31 | 26 |  |
  Mean in minutes (SD) | 79.8 (28.2) | 74.8 (22.6) | 5.0 (− 8.8 to + 18.7) |
 Time participant in ED/N | 25 | 17 |  |
  Mean in minutes (SD) | 2069 (1694) | 2044 (1319) | 25 (− 962 to + 1012) |
 Length of hospital stay/N | 29 | 21 |  |
  Mean in days (SD) | 17.7 (15.2) | 26.8 (24.8) | − 9.1 (− 20.5 to 2.3) |